Clinical Trials Browser

Phase 2 × Interventional × Immunotherapy × Clear all

NCT04225390 2026-02-10

PROMIT

Phase 2 Completed

Immunotherapy

NCT05479240 2023-06-18

Neoadjuvant Chemoradiotherapy Combined With Tislelizumab in the Treatment of Locally Advanced Rectal Cancer

Phase 2 Not yet recruiting

Immunotherapy